Latest News on Drugmakers
Showing of 0 - 10 from 22 results
Drugmakers - Total results - 22
Mar 12, 2018
Novartis CEO Narasimhan rehauls co leadership as operations president Andre Wyss exitsNovartis’ new Chief Executive Vas Narasimhan is remaking the Swiss drugmaker’s leadership as operations president Andre Wyss exits
May 27, 2017
Facebook plans to sell advertisements to pharmaceutical industryFacebook will host a summit in June that is dedicated to health and aims to sell ads to the pharmaceutical industry, a media report said.
Sep 12, 2016
Alphabet partners with Sanofi to form a $500 million joint ventureFrench drugmaker Sanofi and Google owner Alphabet's life sciences firm Verily are to invest about $500 million in a diabetes joint venture combining devices with services, an example of growing ties between the pharma and tech sectors.
Aug 01, 2016
Google parent Alphabet and GlaxoSmithKline form a new companyGlaxoSmithKline and Google parent Alphabet's life sciences unit are creating a new company focused on fighting diseases by targeting electrical signals in the body, jump-starting a novel field of medicine called bioelectronics.
Sep 03, 2015
Overweight Indian pharma stocks defy Asian market rout. Here's whySo far this year, Lupin Ltd has climbed 32 percent, Dr. Reddy's 31 percent, Glenmark Pharmaceuticals 42 percent and Wockhardt 29 percent
Apr 28, 2015
Sun Pharma maybe willing to shell out $7 bn on further acquisitionsSun Pharmaceuticals Industries, emboldened by its takeover of domestic rival Ranbaxy Laboratories, is willing to spend as much as $7 billion on further acquisitions, bankers familiar with the generic drugmaker's strategy said.
Feb 24, 2015
US drugmaker Merck grants free license for pediatric HIV drugDrugmaker Merck & Co. has granted a free license allowing one of its HIV medicines to be made and sold inexpensively for use in young children in poor countries hard hit by the AIDS virus.
Oct 07, 2014
Drugmaker Cipla to set up Rs 225 cr manufacturing plant in IranSetting up the plant will help in faster registrations of new products and will improve its competitive position, the company said, adding it does not expect any impact on its U.S. and European businesses due to its investments in Iran.
Sep 04, 2014
India battles HIV/AIDS drug shortage as some firms halt supplyIndia is facing a shortage of HIV/AIDS drugs provided under government's free medicine programme after drugmakers halted supplies due to delayed payment
Aug 25, 2014
All-cash deal: Roche to buy US biotech firm InterMune for $8.3 bnRoche Holding AG has agreed to buy US biotech company InterMune Inc for $8.3 billion in cash, marking the latest multibillion-dollar deal in a consolidating pharmaceutical sector.